US.HUM · Humana

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.5,
      "details": {
        "atrPct": 4.582687939574724,
        "turnoverUsdM": 1179.0191166500001,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 331.9188,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 3
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 9.2,
      "take_profit_price": 406.2414,
      "target_multiplier": 1.9,
      "technical_strength": 1.93,
      "take_profit_percent": 11.2
    },
    "positionPoints": 1.5,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2219902541563157,
    "stopLossPercent": 9.165375879149448,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 56.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 41.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 15
  },
  "market": {
    "ma20": 395.309,
    "ma50": 365.3706,
    "close": 365.41,
    "prevClose": 388.71,
    "avgVolume20": 1436103,
    "volumeRatio": 2.25,
    "changePercent": -5.99
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 15,
    "details": {
      "ret_5d": -0.08096078770219339,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 15,
      "vcp_bonus": 0,
      "vol_ratio": 2.3861595917763645,
      "ret_points": 0,
      "vol_points": 8,
      "range_ratio": 2.8893281765977585,
      "volat_points": 4,
      "day_range_pct": 0.10730050901726831,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 56.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 5.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 36,
        "contribution": 5.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.1,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 61,
        "contribution": 6.1
      },
      {
        "raw": 15.6,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 52,
        "contribution": 15.6
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 41.2,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 5.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.1/10分",
      "技術信號分析總分: 15.6/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 5.2,
      "市場環境": 5.4,
      "情緒分析": 4,
      "技術信號": 15.6,
      "風險管理": 6.1
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 1179.0191166500001,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.21
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 704.3249969000001,
                "ma50": 715.8034021999999,
                "name": "QQQ",
                "close": 661.63,
                "points": 0.4
              },
              "spy": {
                "ma20": 745.7855067000002,
                "ma50": 744.6632029799998,
                "name": "SPY",
                "close": 729.46002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 4.582687939574724,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141057198,
                "url": "https://finnhub.io/api/news?id=f8552d103d34c3eed0e03e84cfae9fd81193907771b556811b57571c8ef86b6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc (HUM) outlines its strategy for margin growth and operational efficiency amidst planned market exits and cost management initiatives.",
                "category": "company",
                "datetime": 1785351815,
                "headline": "Humana Inc (HUM) Q2 2026 Earnings Call Highlights: Strategic Exits and Margin Expansion Plans"
              },
              {
                "id": 141054370,
                "url": "https://finnhub.io/api/news?id=a8d7e4ae03deb08fd5ec2696f8f75246750d42320177e4063bf8b01f39e90bf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
                "category": "company",
                "datetime": 1785335402,
                "headline": "Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics"
              },
              {
                "id": 141054371,
                "url": "https://finnhub.io/api/news?id=05f4cfa8318cf163dae3c7ef01b4922555e92af1dc00cb7d556089b208ea179a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock has delivered a powerful run over the past year, yet on the current checks it no longer looks obviously cheap or obviously expensive. The recent share price strength now sits alongside a mixed valuation score and an earnings multiple picture that suggests the market may be close to fair on the stock. Humana has returned 69.5% over the past year, which puts more pressure on today’s buyers to be confident about what they are paying for. Expectations for ongoing healthcare demand...",
                "category": "company",
                "datetime": 1785334135,
                "headline": "Humana (HUM) Stock Looks Fairly Valued Despite Its 70% Run"
              },
              {
                "id": 141052233,
                "url": "https://finnhub.io/api/news?id=d0c23ec513b04d1edfd7e0d869fb9785a48fe225b1123f3fb8378e65c864b0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785324849,
                "headline": "Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations"
              },
              {
                "id": 141053216,
                "url": "https://finnhub.io/api/news?id=5541c542f58c7b5a511ed1cd2bede47c1fed62a45eab3ebb9478b69f6bf2b049",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) delivered earnings and revenue surprises of +22.35% and +0.59%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785324605,
                "headline": "Humana (HUM) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141051933,
                "url": "https://finnhub.io/api/news?id=0ea0ca902da6eeb86183a85ca1b5803bbb701e70a9cb175e17ed68a94a200af8",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Humana (HUM) Q2 2026 adjusted EPS beat at $7.61, but revenue slightly missed; stock fell 7% after cutting GAAP outlook while reaffirming adjusted guidance.",
                "category": "company",
                "datetime": 1785324389,
                "headline": "Humana (NYSE:HUM) Slumps After Q2 Beat as GAAP Guidance Cut Overshadows Strong Earnings"
              },
              {
                "id": 141053701,
                "url": "https://finnhub.io/api/news?id=b61af01257df40578b370e166792fdff0584cc566e5915b20839f9da339d8009",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana Inc. (HUM) Q2 2026 Earnings Call July 29, 2026 8:00 AM EDTCompany ParticipantsLisa Stoner - Vice President of Investor RelationsJames Rechtin -...",
                "category": "company",
                "datetime": 1785323603,
                "headline": "Humana Inc. (HUM) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141051614,
                "url": "https://finnhub.io/api/news?id=49834f02668227a247c046b6c9ef481f8c208ee8172c7929c4e7fd24ef1ea0df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) is back in focus after new research from Humana Healthcare Research on Medicare Advantage selection coincided with rising attention on the company’s upcoming earnings report and its revised profit expectations for the quarter. See our latest analysis for Humana. At a share price of $388.71, Humana has seen strong momentum build, with a 90 day share price return of 59.88% and a 1 year total shareholder return of 69.51%, even though the 3 year and 5 year total shareholder returns...",
                "category": "company",
                "datetime": 1785312604,
                "headline": "Humana (HUM) Could Be 83% Overvalued On Medicare Advantage Study And Earnings Focus"
              }
            ],
            "raw_source": [
              {
                "id": 141057198,
                "url": "https://finnhub.io/api/news?id=f8552d103d34c3eed0e03e84cfae9fd81193907771b556811b57571c8ef86b6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc (HUM) outlines its strategy for margin growth and operational efficiency amidst planned market exits and cost management initiatives.",
                "category": "company",
                "datetime": 1785351815,
                "headline": "Humana Inc (HUM) Q2 2026 Earnings Call Highlights: Strategic Exits and Margin Expansion Plans"
              },
              {
                "id": 141055135,
                "url": "https://finnhub.io/api/news?id=4dc12047b41ce397449a1555482561b53f25523ac38d9977a9ca33d8022dc596",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.",
                "category": "company",
                "datetime": 1785344700,
                "headline": "Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session."
              },
              {
                "id": 141057467,
                "url": "https://finnhub.io/api/news?id=e360f11a86bd99bdfd794672a159e7c2b46b62848aefe150461ba96a55d41f83",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/78567889/image_78567889.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana Inc. aims for a 3% pre-tax margin by 2028 via Medicare Advantage quality and cost cuts. Click for this HUM earnings update.",
                "category": "company",
                "datetime": 1785342262,
                "headline": "Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track"
              },
              {
                "id": 141055757,
                "url": "https://finnhub.io/api/news?id=8bab581e89b64142f1da8398b89a2fab0c037087dc924106ed3b864fce3e48e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Q2 Earnings Season in Full Swing",
                "category": "company",
                "datetime": 1785338940,
                "headline": "Q2 Earnings Season in Full Swing"
              },
              {
                "id": 141055751,
                "url": "https://finnhub.io/api/news?id=53d28f66396443a157c170dee0577554538e51740747ecca6013d4ce76ae6b32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM's Q2 earnings top estimates as medical membership growth, premium gains and CenterWell strength lift results despite higher costs.",
                "category": "company",
                "datetime": 1785338580,
                "headline": "Humana Q2 Earnings Beat Estimates on Medical Membership Growth"
              },
              {
                "id": 141054368,
                "url": "https://finnhub.io/api/news?id=d5e86411c5dc8e9fe060a5ada62808565f4a3ef49be60928ca0102bdd104f86b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth.  GEHC broke above its recent trading range that followed its dive on Q1 results.  Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.",
                "category": "company",
                "datetime": 1785337536,
                "headline": "S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings"
              },
              {
                "id": 141054369,
                "url": "https://finnhub.io/api/news?id=327f060cbb02d4d9d05c91fe2f3acb2cea50a9dac2f2f3785a97470c22f34420",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A quarter-points rate hike has been bandied about as a possibility today.",
                "category": "company",
                "datetime": 1785336300,
                "headline": "Investors Await Fed Decision Today"
              },
              {
                "id": 141053559,
                "url": "https://finnhub.io/api/news?id=f55fa417a0e86f594f23765075c68cbd56c74801522c2eb9f068e3949fd21792",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1785335701,
                "headline": "Wednesday's session: gap up and gap down stock in the S&P500 index"
              },
              {
                "id": 141054370,
                "url": "https://finnhub.io/api/news?id=a8d7e4ae03deb08fd5ec2696f8f75246750d42320177e4063bf8b01f39e90bf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
                "category": "company",
                "datetime": 1785335402,
                "headline": "Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics"
              },
              {
                "id": 141054371,
                "url": "https://finnhub.io/api/news?id=05f4cfa8318cf163dae3c7ef01b4922555e92af1dc00cb7d556089b208ea179a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock has delivered a powerful run over the past year, yet on the current checks it no longer looks obviously cheap or obviously expensive. The recent share price strength now sits alongside a mixed valuation score and an earnings multiple picture that suggests the market may be close to fair on the stock. Humana has returned 69.5% over the past year, which puts more pressure on today’s buyers to be confident about what they are paying for. Expectations for ongoing healthcare demand...",
                "category": "company",
                "datetime": 1785334135,
                "headline": "Humana (HUM) Stock Looks Fairly Valued Despite Its 70% Run"
              },
              {
                "id": 139799744,
                "url": "https://finnhub.io/api/news?id=ee81d23e3c82c3f8a5ee03d58f0fc4013fe3127fb16979d35a582aaaeee4712c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785332699,
                "headline": "Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141056821,
                "url": "https://finnhub.io/api/news?id=a69ae2fd0894af4bbe9d9da2de7351f66d1698cedc0f51267d81cb7723dc48f7",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/29/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.",
                "category": "company",
                "datetime": 1785330320,
                "headline": "Humana's Strong Quarter Fails To Impress"
              },
              {
                "id": 141053136,
                "url": "https://finnhub.io/api/news?id=2b9707938c530e89b448569672154c6e44345d1e07aa005c54bd56b843cdfe59",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1%, and the actively t",
                "category": "company",
                "datetime": 1785328722,
                "headline": "Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed's Interest Rate Announcement"
              },
              {
                "id": 141052519,
                "url": "https://finnhub.io/api/news?id=d12ea2b97a7b8de7d8605f8f43bbe2a535312469ed9993773e3e6f01acd75ef9",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1785328501,
                "headline": "Get insights into the top movers in the S&P500 index of Wednesday's pre-market session."
              },
              {
                "id": 141053214,
                "url": "https://finnhub.io/api/news?id=fb1a6049721baa6d7b46278b6195bd7c00ddf9914757df84a6461b764aaf696d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) shares fell nearly 9% in pre-market trading on Wednesday despite the health insurer reporting second-quarter earnings and revenue that exceeded Wall Street expectations while reaffirming its full-year adjusted earnings guidance.",
                "category": "company",
                "datetime": 1785327467,
                "headline": "Humana Shares Fall Despite Second-Quarter Earnings Beat and Reaffirmed Outlook"
              },
              {
                "id": 141052917,
                "url": "https://finnhub.io/api/news?id=c73ec1e45071df7ab6cf027726410cb65ae0a0f6ec8c56db89e4703ca4176140",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The main US stock measures were mostly trending higher in Wednesday's premarket activity as traders",
                "category": "company",
                "datetime": 1785326392,
                "headline": "Stocks Mostly Up Pre-Bell Ahead of Fed Rate Decision, Big Tech Earnings"
              },
              {
                "id": 141052233,
                "url": "https://finnhub.io/api/news?id=d0c23ec513b04d1edfd7e0d869fb9785a48fe225b1123f3fb8378e65c864b0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785324849,
                "headline": "Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations"
              },
              {
                "id": 141053216,
                "url": "https://finnhub.io/api/news?id=5541c542f58c7b5a511ed1cd2bede47c1fed62a45eab3ebb9478b69f6bf2b049",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) delivered earnings and revenue surprises of +22.35% and +0.59%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785324605,
                "headline": "Humana (HUM) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141051933,
                "url": "https://finnhub.io/api/news?id=0ea0ca902da6eeb86183a85ca1b5803bbb701e70a9cb175e17ed68a94a200af8",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Humana (HUM) Q2 2026 adjusted EPS beat at $7.61, but revenue slightly missed; stock fell 7% after cutting GAAP outlook while reaffirming adjusted guidance.",
                "category": "company",
                "datetime": 1785324389,
                "headline": "Humana (NYSE:HUM) Slumps After Q2 Beat as GAAP Guidance Cut Overshadows Strong Earnings"
              },
              {
                "id": 141053701,
                "url": "https://finnhub.io/api/news?id=b61af01257df40578b370e166792fdff0584cc566e5915b20839f9da339d8009",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana Inc. (HUM) Q2 2026 Earnings Call July 29, 2026 8:00 AM EDTCompany ParticipantsLisa Stoner - Vice President of Investor RelationsJames Rechtin -...",
                "category": "company",
                "datetime": 1785323603,
                "headline": "Humana Inc. (HUM) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141052234,
                "url": "https://finnhub.io/api/news?id=c28f79576635d146acdf2ddc6e866df7dd2412c0054ac14c5a6cf07e6868071d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health insurer revised its full-year GAAP earnings guidance to at least $6.52 a share, down from at least $8.36",
                "category": "company",
                "datetime": 1785323276,
                "headline": "Humana cuts 2026 profit outlook on lower Medicare star ratings"
              },
              {
                "id": 141052218,
                "url": "https://finnhub.io/api/news?id=eeeb47f4a70334a61d004598296f6ee769f94a81ef86b704a233383585320092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., July 29, 2026--Humana Inc. (NYSE: HUM) today announced that the Company’s Board of Directors has elected Paul Smith and Frederick Crawford as new Board members, effective immediately.",
                "category": "company",
                "datetime": 1785322800,
                "headline": "Humana Elects Paul Smith and Frederick Crawford to Board of Directors"
              },
              {
                "id": 141052236,
                "url": "https://finnhub.io/api/news?id=adbeee8812a44cab032bfde8a1fc547f00724c753b082ac4dd02155a3611f09f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Humana Inc. (NYSE: HUM) reported second-quarter earnings before the open on Wednesday, topping consensus expectations.",
                "category": "company",
                "datetime": 1785321954,
                "headline": "Humana falls despite beating second quarter estimates"
              },
              {
                "id": 141052151,
                "url": "https://finnhub.io/api/news?id=f5f80e1ed7da3428606a70bdff1c7fd73533b4a7d1c50efe913c1d9f8efe01c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana reports a higher medical cost ratio and reaffirms, rather than raises, its full-year earnings guidance.",
                "category": "company",
                "datetime": 1785320640,
                "headline": "Why Humana Stock Is Falling After Earnings Beat Expectations"
              },
              {
                "id": 141052238,
                "url": "https://finnhub.io/api/news?id=e987c16d3b22ae1c85a61dec113d79add3afc99014e07f573cd79881900d61f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., July 29, 2026--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2026 (2Q26) versus the quarter ended June 30, 2025 (2Q25) and for the six months ended June 30, 2026 (YTD 2026) versus the six months ended June 30, 2025 (YTD 2025) as noted in the tables below.",
                "category": "company",
                "datetime": 1785319200,
                "headline": "Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance"
              },
              {
                "id": 141055320,
                "url": "https://finnhub.io/api/news?id=594083776bc884a7bdb498ebc39608f67adf5e667524d2f304b65f338119eab1",
                "image": "https://image.cnbcfm.com/api/v1/image/108341672-1785328931386-gettyimages-2287298854-img_2575.jpeg?v=1785328962&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a \"disappointment\" amid high expectations for insurers.",
                "category": "company",
                "datetime": 1785317000,
                "headline": "Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line"
              },
              {
                "id": 141051614,
                "url": "https://finnhub.io/api/news?id=49834f02668227a247c046b6c9ef481f8c208ee8172c7929c4e7fd24ef1ea0df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) is back in focus after new research from Humana Healthcare Research on Medicare Advantage selection coincided with rising attention on the company’s upcoming earnings report and its revised profit expectations for the quarter. See our latest analysis for Humana. At a share price of $388.71, Humana has seen strong momentum build, with a 90 day share price return of 59.88% and a 1 year total shareholder return of 69.51%, even though the 3 year and 5 year total shareholder returns...",
                "category": "company",
                "datetime": 1785312604,
                "headline": "Humana (HUM) Could Be 83% Overvalued On Medicare Advantage Study And Earnings Focus"
              },
              {
                "id": 141055946,
                "url": "https://finnhub.io/api/news?id=ef4989b37e96defc10e2b47137708e0d18ad8074a3d1e6861cd983d3f2525106",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The insurer is laser-focused on reaching margin targets, and will sacrifice some plans with lower returns next year to do so, CFO Celeste Mellet said.",
                "category": "company",
                "datetime": 1785309097,
                "headline": "Humana to exit more Medicare Advantage plans in 2027"
              },
              {
                "id": 141056822,
                "url": "https://finnhub.io/api/news?id=411ceda646fbc52f9f0e20268e25c252d64c39ebc60940bee762e9a29682632e",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) FY2026  expected to be more than $6.52 vs $8.55 Est..",
                "category": "company",
                "datetime": 1785304941,
                "headline": "Humana FY2026 GAAP EPS expected to be more than $6.52 vs $8.55 Est"
              },
              {
                "id": 141056823,
                "url": "https://finnhub.io/api/news?id=540e3d8da7c8ed7316c53cfc3e2c13b4407f2b09ba7d82d72b56fb3b7de19053",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) FY2026  expected to be more than $9.00 vs $8.94 Est..",
                "category": "company",
                "datetime": 1785304934,
                "headline": "Humana FY2026 Adj EPS expected to be more than $9.00 vs $8.94 Est"
              },
              {
                "id": 141056824,
                "url": "https://finnhub.io/api/news?id=bdcda3e625083cba28d2014f3af49790c2517a82969e62e41f4872c1ffb51e26",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/29/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (HUM) will release Q2 earnings on July 29. Analysts expect $7 EPS and $40.57B revenue. Recent deals and ratings show potential. #HUM",
                "category": "company",
                "datetime": 1785293082,
                "headline": "Humana Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts"
              },
              {
                "id": 141047520,
                "url": "https://finnhub.io/api/news?id=767a0ad3952bb7b868fb1f62d557f9a17b181295616fba5184029f792f9359ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana reports earnings Wednesday after its stock surged this year on improving confidence in Medicare Advantage insurers. Investors will be watching medical costs and the company’s outlook.",
                "category": "company",
                "datetime": 1785271080,
                "headline": "Humana Earnings Face High Expectations as Medicare Advantage Recovers"
              },
              {
                "id": 141055210,
                "url": "https://finnhub.io/api/news?id=af225958a6e90dea1bce3e89e151f1d41858e84fc534d0cd99cb597285121846",
                "image": "https://image.cnbcfm.com/api/v1/image/108323516-1785331942032-108323516-1781724683119-gettyimages-2281465619-WARSH_FOMC_NYSE.jpg?v=1785331950&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The Dow is coming off its third straight winning day.",
                "category": "company",
                "datetime": 1785261759,
                "headline": "Dow falls more than 700 points as oil rises ahead of Fed decision: Live updates"
              },
              {
                "id": 141046976,
                "url": "https://finnhub.io/api/news?id=ee99550e65d283f8fc6944965013ad47621413e2f6544d5e671d18f30d079119",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "https://www.wsj.com/health/healthcare/trump-administration-to-end-medicare-drug-plan-subsidy-76d255d1",
                "category": "company",
                "datetime": 1785254534,
                "headline": "'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive"
              },
              {
                "id": 141044040,
                "url": "https://finnhub.io/api/news?id=e2f4b1597f898066a8eadf81dfc30f115dd89681eadb603e194e41f943475a90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "When a hospital system drops a Medicare Advantage contract, the patient's carefully chosen cardiologist can vanish overnight, and the window to fix it without consequences closes faster than most retirees realize.",
                "category": "company",
                "datetime": 1785251020,
                "headline": "25 Health Systems Have Dropped Medicare Advantage in 2026. Here’s What Enrollees Should Do Now."
              },
              {
                "id": 141042744,
                "url": "https://finnhub.io/api/news?id=2b5d93478a0070b4cfc21b4e019fbf1d6de3c1f4410d61f42b7556f078b93198",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., July 28, 2026--A new study from Humana Healthcare Research (HHR), published in Health Affairs Scholar, finds that favorable selection in Medicare Advantage (MA) may be significantly lower than commonly cited estimates suggest. Favorable selection refers to the extent to which MA enrollees incur lower costs than predicted after risk adjustment and is an important factor in MA payment policy debates. The study found that a single methodological refinement substantially reduced fav",
                "category": "company",
                "datetime": 1785247200,
                "headline": "New Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates"
              },
              {
                "id": 141044041,
                "url": "https://finnhub.io/api/news?id=e9a408c687a9e89d36cd734ac851f3ef74003133d82fad4ebd724d72ba136dcf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785244508,
                "headline": "Gear Up for Humana (HUM) Q2 Earnings: Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141042745,
                "url": "https://finnhub.io/api/news?id=7244d5ba75603d5242f9e3892bdf072bd65c3db46ea77410b902c33db270ea82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know.",
                "category": "company",
                "datetime": 1785242222,
                "headline": "Humana (HUM) Reports Q2: Everything You Need To Know Ahead Of Earnings"
              },
              {
                "id": 141042399,
                "url": "https://finnhub.io/api/news?id=636e6876032e77d8e72732ddd75f2acb8ecd9a7d6233a757896254532f03b6d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DENVER, July 28, 2026--As artificial intelligence reshapes cybersecurity, risk management, and enterprise leadership, organizations are looking for practical strategies—not just predictions—to navigate what's next. From November 4-6, more than 700 executive leaders will gather at the Gaylord Rockies Resort & Convention Center in Denver, Colorado, for the EWF Annual Conference.",
                "category": "company",
                "datetime": 1785240000,
                "headline": "As AI Reshapes Cybersecurity, EWF 2026 Brings Together Industry Leaders to Deliver Practical Solutions"
              },
              {
                "id": 141041785,
                "url": "https://finnhub.io/api/news?id=05331852a7fabd0d89cd994e30b93d517cda0768c3cccd460d522c8400fc7c69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin pressures.",
                "category": "company",
                "datetime": 1785229320,
                "headline": "The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals"
              },
              {
                "id": 141035247,
                "url": "https://finnhub.io/api/news?id=3ce6310c5a7787015ebdff11b4a2487d30095a481eeaf725620e2ed8721805d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.",
                "category": "company",
                "datetime": 1785168180,
                "headline": "4 Medical Stocks With the Right Setup for Q2 Earnings Beats"
              },
              {
                "id": 141036164,
                "url": "https://finnhub.io/api/news?id=a6b6c6d4c90a0bb74ebbcd36a3334c681541ab8ecc3c1dd3fb8a84bf94227e17",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1785159309,
                "headline": "4 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141053131,
                "url": "https://finnhub.io/api/news?id=7043adeae041cf21f37d02e1bb6cd835bc9ea1447c64a086dfc789612b0beffe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Earnings season kicks into high gear this week.",
                "category": "company",
                "datetime": 1785153127,
                "headline": "Earnings live: Humana stock falls, Procter & Gamble dips, with Big Tech earnings on deck"
              },
              {
                "id": 141024010,
                "url": "https://finnhub.io/api/news?id=2c5db92c8ab827ee6f3b90cbf33fde6ea6c56be2eb02d39168027e8407bb46f0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/803420378/image_803420378.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The series targets generating 12–15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strategy here.",
                "category": "company",
                "datetime": 1785053700,
                "headline": "Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)"
              },
              {
                "id": 141010762,
                "url": "https://finnhub.io/api/news?id=34cf0495c3aad32ad59c71b73880c9d0cf75062d6a008f74ecd1fff6c757b090",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.",
                "category": "company",
                "datetime": 1784926584,
                "headline": "The Real Price of UnitedHealth Stock Is Two Years Away"
              },
              {
                "id": 141007777,
                "url": "https://finnhub.io/api/news?id=ec70fca7d4366d7d7666d1585311865e707df9f66c2e2a1ea1135a70b6f4f642",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.",
                "category": "company",
                "datetime": 1784911140,
                "headline": "Can Humana Beat Q2 Earnings Estimates on Growing Premiums?"
              },
              {
                "id": 140997787,
                "url": "https://finnhub.io/api/news?id=62fce0608d45e410c0de9b5328f24b3e6e5af974a2273c77868794b05275e66a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.",
                "category": "company",
                "datetime": 1784830020,
                "headline": "MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised"
              },
              {
                "id": 140984930,
                "url": "https://finnhub.io/api/news?id=fa3b0d57e25d8e6cb4497512fc0df9a3d95b9be42b23bd96dc0f8bf250b2e539",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.",
                "category": "company",
                "datetime": 1784734860,
                "headline": "Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates"
              },
              {
                "id": 140983295,
                "url": "https://finnhub.io/api/news?id=03ef70f48439c08cb657f244d062289c23c93721dae9698fffbc05e182674506",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company",
                "category": "company",
                "datetime": 1784729142,
                "headline": "Healthcare Services Group Q2 Earnings Call Highlights"
              },
              {
                "id": 140983296,
                "url": "https://finnhub.io/api/news?id=2f88f7edb241eee023f490969f9596d7234726429243eaa176e8d9452e28ecde",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784728817,
                "headline": "Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?"
              },
              {
                "id": 140983761,
                "url": "https://finnhub.io/api/news?id=96be1c9a57931cb47d1e6d9d1241589e4644addd7b819db5dfae61b589c0610f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340690121/image_1340690121.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions.",
                "category": "company",
                "datetime": 1784723700,
                "headline": "Nomura Core Equity Fund Q2 2026 Portfolio Review"
              },
              {
                "id": 140976384,
                "url": "https://finnhub.io/api/news?id=57236c5052f85582eb5ea0f555f013f41560f1273e2f5734bc67c62a45028091",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.",
                "category": "company",
                "datetime": 1784669171,
                "headline": "The Hidden Engine Behind Elevance Health Stock's Next Climb"
              },
              {
                "id": 140976385,
                "url": "https://finnhub.io/api/news?id=82aea808c7ba6dd8cc4c52c74c0cbb24ac81eca4dffdd8eaae25d25ec6adcf2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.",
                "category": "company",
                "datetime": 1784665995,
                "headline": "What Kept Coming Up When Analysts Grilled UNH"
              },
              {
                "id": 140973550,
                "url": "https://finnhub.io/api/news?id=581d7ae2f0ed8441fe2ddce2539424bfd1dc642f82930dcd4b0aff3348adf712",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.",
                "category": "company",
                "datetime": 1784649602,
                "headline": "Humana (HUM) is a Great Momentum Stock: Should You Buy?"
              },
              {
                "id": 140973836,
                "url": "https://finnhub.io/api/news?id=e98bbcd3c40e9eb1c069bf812abf8cb1de619dd38fa0d0df460fe4f786bb9509",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1784640912,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140964592,
                "url": "https://finnhub.io/api/news?id=58f2422d303d8abfa6b6a25d4132328b6a814c3f9522481f3742d3a550f5e74e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/20/Medicare-Advantage.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older",
                "category": "company",
                "datetime": 1784568273,
                "headline": "2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027"
              },
              {
                "id": 140960646,
                "url": "https://finnhub.io/api/news?id=26611f7250ba7764b0a74ecf69e8ba7e9451005d8c6eacbd3be4626ede25f15c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.",
                "category": "company",
                "datetime": 1784558582,
                "headline": "The Real Risk Inside UnitedHealth Stock"
              },
              {
                "id": 140943913,
                "url": "https://finnhub.io/api/news?id=8fd449448850298f62e831c5153f5e7b5eeba6e698856c04f71fea7a48da00d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock’s analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within a Medical HMO industry that has itself risen meaningfully this year, highlights growing confidence in Humana’s business relative to peers. Now we will explore how this stronger...",
                "category": "company",
                "datetime": 1784387510,
                "headline": "Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?"
              },
              {
                "id": 140939166,
                "url": "https://finnhub.io/api/news?id=abb851b8ee2d464a110b910c89dadec490fc80b6db6ddf24abbb5c7ae870adf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.",
                "category": "company",
                "datetime": 1784326192,
                "headline": "What A Patient Holder Is Really Paying For CVS Health Stock"
              },
              {
                "id": 140939174,
                "url": "https://finnhub.io/api/news?id=50dc6e76d1c3aa89467680e6bc1cf51c7a2b8faf7bea9022ea161510d8c648b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.",
                "category": "company",
                "datetime": 1784325720,
                "headline": "What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?"
              },
              {
                "id": 140935745,
                "url": "https://finnhub.io/api/news?id=66569f4b63aaf34234d1daceaa2b07b4c21c46e1e9988c5dc64bf093a47bc25f",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.",
                "category": "company",
                "datetime": 1784315101,
                "headline": "Discover which S&P500 stocks are making waves on Friday."
              },
              {
                "id": 140933182,
                "url": "https://finnhub.io/api/news?id=90fc7fee0402e1dc63ffe5138a2d11e510b6b842fcfad964500c5daabf553e41",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1784295649,
                "headline": "Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?"
              },
              {
                "id": 140926098,
                "url": "https://finnhub.io/api/news?id=a3ed218800a97680c73e07aa6bb488836ce3c983719dca490e71b4cd424977f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.",
                "category": "company",
                "datetime": 1784233476,
                "headline": "UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates"
              },
              {
                "id": 140924354,
                "url": "https://finnhub.io/api/news?id=6beff7ff98afeafc7e69e28d5375177dc8b70c8486507b5409de1426713e60de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs, sending the Dow Jones stock surging past a buy point on Thursday morning.  Rival managed-care providers including Humana, Centene and Elevance Health got a sizable lift from the initial warm reception for UnitedHealth's earnings report.  Results: UnitedHealth posted Q2 earnings per share of $6.38, up 56% from a weak year-earlier result and 30% ahead of $4.91 forecasts.",
                "category": "company",
                "datetime": 1784230057,
                "headline": "Why UNH Stock Breakout Faltered After Massive Earnings Beat"
              },
              {
                "id": 140922832,
                "url": "https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",
                "category": "company",
                "datetime": 1784218802,
                "headline": "Can Humana (HUM) Run Higher on Rising Earnings Estimates?"
              },
              {
                "id": 140921098,
                "url": "https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.",
                "category": "company",
                "datetime": 1784213644,
                "headline": "UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"
              },
              {
                "id": 140920951,
                "url": "https://finnhub.io/api/news?id=4edc50fb0c0b3163368a3ac06c10ca151d88a91c32421f42358d93e3f325254f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.",
                "category": "company",
                "datetime": 1784211300,
                "headline": "Sandisk, Micron, TSMC, UnitedHealth, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140923118,
                "url": "https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.",
                "category": "company",
                "datetime": 1784208257,
                "headline": "UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"
              },
              {
                "id": 140919761,
                "url": "https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.",
                "category": "company",
                "datetime": 1784207995,
                "headline": "The Medicaid Problem That Swallowed an Earnings Beat"
              },
              {
                "id": 140919767,
                "url": "https://finnhub.io/api/news?id=5bce92d51784c68c7f17ff30ac90cfadc42527df5e6f98bcf7d33ff3a800eb62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.",
                "category": "company",
                "datetime": 1784205720,
                "headline": "Inside the UnitedHealth Earnings Beat That Lifted Healthcare Stocks"
              },
              {
                "id": 140919291,
                "url": "https://finnhub.io/api/news?id=195f8e2045a457bd41c82088ca85aafdc16620b26b540f6e0008b4d2a9b08064",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1784205300,
                "headline": "What's going on in today's pre-market session: S&P500 movers"
              },
              {
                "id": 140919768,
                "url": "https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.",
                "category": "company",
                "datetime": 1784205032,
                "headline": "The Medicaid Problem Weighing On Elevance Health Stock"
              },
              {
                "id": 140919728,
                "url": "https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.",
                "category": "company",
                "datetime": 1784205031,
                "headline": "The Real Price of Admission for CVS Health Stock"
              },
              {
                "id": 140919679,
                "url": "https://finnhub.io/api/news?id=54e2d3441d9dc3c895613df0f8f0e6192543381b162933236b00e7b8c37b72f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.",
                "category": "company",
                "datetime": 1784204340,
                "headline": "Sandisk, UnitedHealth, J.B. Hunt, TSMC, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140920007,
                "url": "https://finnhub.io/api/news?id=b05572daf0c4b7738b01cacb08bf0110183587e578a16a35f389f0c74c58a89a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) delivered earnings and revenue surprises of +29.15% and +1.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784199902,
                "headline": "UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates"
              },
              {
                "id": 140918841,
                "url": "https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook.  Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.",
                "category": "company",
                "datetime": 1784199650,
                "headline": "UNH Stock Flashes Buy Signal On Massive Earnings Beat"
              },
              {
                "id": 140918843,
                "url": "https://finnhub.io/api/news?id=cf5cb36802c45abb2a183490e32f65c7eec1280c026b62d4e243a0196161334b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.",
                "category": "company",
                "datetime": 1784198280,
                "headline": "UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost"
              },
              {
                "id": 140923188,
                "url": "https://finnhub.io/api/news?id=d85d188ac31f0be7b67de702da053ebe6f33ee097b1395995d39e56ab6610ae9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/GLP-1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you",
                "category": "company",
                "datetime": 1784193389,
                "headline": "Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027"
              },
              {
                "id": 140914116,
                "url": "https://finnhub.io/api/news?id=e9db35be5692d32311636bfb2d472068853dd38721681a09228157e8ca04b9d7",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1163752700/image_1163752700.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana stock surged 106% on Medicare Advantage optimism, but margins and earnings lag and valuation looks stretched. Click for more on HUM stock.",
                "category": "company",
                "datetime": 1784137230,
                "headline": "Humana: Q2 Earnings Must Catch Up With The Stock"
              },
              {
                "id": 140907461,
                "url": "https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.",
                "category": "company",
                "datetime": 1784114481,
                "headline": "Insurance stocks fall after Elevance Health results show margin pressure"
              },
              {
                "id": 140906296,
                "url": "https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...",
                "category": "company",
                "datetime": 1784095786,
                "headline": "Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"
              },
              {
                "id": 140901947,
                "url": "https://finnhub.io/api/news?id=5f3fef99ff0df0cac06252e71b332ffd16257eb940089d3f03c9ff846d60da6c",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "TD Cowen  analyst Ryan Langston   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $211 to $350.",
                "category": "company",
                "datetime": 1784028528,
                "headline": "TD Cowen Maintains Hold on Humana, Raises Price Target to $350"
              },
              {
                "id": 140901948,
                "url": "https://finnhub.io/api/news?id=3c52092a2a30d09e2f4291941a91a1161fec0a8e29e89d8fa52bd0d1ff2215ef",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Truist Securities  analyst David Macdonald   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $320 to $415.",
                "category": "company",
                "datetime": 1784021510,
                "headline": "Truist Securities Maintains Hold on Humana, Raises Price Target to $415"
              },
              {
                "id": 140893488,
                "url": "https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1783995721,
                "headline": "Wells Fargo Upgrades Humana (HUM)"
              },
              {
                "id": 140890161,
                "url": "https://finnhub.io/api/news?id=e25110c78ca2177615e41497f4272b141937d60a5e1b269003abf9d7270f7d7c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and",
                "category": "company",
                "datetime": 1783971281,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 140890023,
                "url": "https://finnhub.io/api/news?id=495aea92af0bbd7e19a383216dfbd22c522dee63025845643456bbfaa14d3c16",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.",
                "category": "company",
                "datetime": 1783965840,
                "headline": "Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch"
              },
              {
                "id": 140890002,
                "url": "https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.",
                "category": "company",
                "datetime": 1783965262,
                "headline": "The Premium On CVS Stock Vs What Its Peers Deliver"
              },
              {
                "id": 140888416,
                "url": "https://finnhub.io/api/news?id=fd4d4d323ca3fedefea2cc6d440ffd8cf63824e0800c451fe6d924a57bcada11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.",
                "category": "company",
                "datetime": 1783960620,
                "headline": "Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?"
              },
              {
                "id": 140885931,
                "url": "https://finnhub.io/api/news?id=d9bd3e5a447e59b21f811bc30301952ad049da7bb5153d18da437fe995ccd6e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "American Express, Biogen upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1783950101,
                "headline": "American Express, Biogen upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 140888858,
                "url": "https://finnhub.io/api/news?id=2ee353ba4819573ae59d8207240fe4802587c3ae7f9647c9333653e00912cd13",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Wells Fargo  analyst Stephen Baxter   upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $227 to $502.",
                "category": "company",
                "datetime": 1783929218,
                "headline": "Wells Fargo Upgrades Humana to Overweight, Raises Price Target to $502"
              },
              {
                "id": 140865405,
                "url": "https://finnhub.io/api/news?id=43b032537d5346775647011af917abc702bf8a42f9ad7ce1513fce3cdf3d5099",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.",
                "category": "company",
                "datetime": 1783707000,
                "headline": "Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?"
              },
              {
                "id": 140864271,
                "url": "https://finnhub.io/api/news?id=2e1f4d2e2bd8a771190b14a8e47325fa8f08b3d3b73ff3f485a97a763923bec7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.",
                "category": "company",
                "datetime": 1783700700,
                "headline": "Is ELV's Capital Allocation Strategy Creating Long-Term Value?"
              },
              {
                "id": 140864272,
                "url": "https://finnhub.io/api/news?id=8cb9ceee7f486eaba0b4c7d9e75a7a6713c50af11938b8057df4ec2e73f044c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.",
                "category": "company",
                "datetime": 1783700580,
                "headline": "Can UNH's Lifestyle Spending Account Redefine Employee Benefits?"
              },
              {
                "id": 140861604,
                "url": "https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.",
                "category": "company",
                "datetime": 1783684540,
                "headline": "UNH Showered Owners With Cash. The Stock Did Not Cooperate"
              },
              {
                "id": 140860584,
                "url": "https://finnhub.io/api/news?id=b0b89f578c00f4ef5ee36881a23109c43fd7c57d2231e57e1adfbc28747b77a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16",
                "category": "company",
                "datetime": 1783683039,
                "headline": "The Main Reason Behind Buying UnitedHealth Before July 16"
              },
              {
                "id": 140860865,
                "url": "https://finnhub.io/api/news?id=3534cd0756dbc13bd4612d305a212cd65ae36ef9141d04b1b4365039c50b020f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1278842473/image_1278842473.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The S&P 500 declined 0.95% as market leadership rotated away from mega-cap tech. Read more here.",
                "category": "company",
                "datetime": 1783671000,
                "headline": "Broadening Market Lifts Moat Stocks In June"
              },
              {
                "id": 140854725,
                "url": "https://finnhub.io/api/news?id=4d4ba33028b72345771b2d6177ef4a48ef6331e93a1f3ef095b421cf04b71092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”",
                "category": "company",
                "datetime": 1783622061,
                "headline": "Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”"
              },
              {
                "id": 140851085,
                "url": "https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.",
                "category": "company",
                "datetime": 1783604827,
                "headline": "The Real Price of UnitedHealth Stock Isn't on Today's Label"
              },
              {
                "id": 140865176,
                "url": "https://finnhub.io/api/news?id=b5b0d6d80e9f8fc9b7209c25c2b2b814f79658f1aba834769155c9e2eafae44d",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "RBC Capital  analyst Ben Hendrix   maintains Humana (NYSE:HUM) with a Sector Perform and raises the price target from $246 to $415.",
                "category": "company",
                "datetime": 1783603928,
                "headline": "RBC Capital Maintains Sector Perform on Humana, Raises Price Target to $415"
              },
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              },
              {
                "id": 140843416,
                "url": "https://finnhub.io/api/news?id=5dd1d143f06f4fa4eb3d3a97880fa22ffc1c5de99e6a64d0a7dcb18a4055d14a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.",
                "category": "company",
                "datetime": 1783524300,
                "headline": "UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?"
              },
              {
                "id": 140834545,
                "url": "https://finnhub.io/api/news?id=2b9ad6b049d73243c2c7d8cc8764c34538c16d53083e94ef5b89809c55698234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.",
                "category": "company",
                "datetime": 1783430767,
                "headline": "Humana Earnings Preview: What to Expect"
              },
              {
                "id": 140830888,
                "url": "https://finnhub.io/api/news?id=7e0083af50961ff361349709b6916fd6b5d1b8e4b89f6a2ba577c788e6b954a8",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Cantor Fitzgerald  analyst Sarah James   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $264 to $300.",
                "category": "company",
                "datetime": 1783410797,
                "headline": "Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300"
              },
              {
                "id": 140822476,
                "url": "https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.",
                "category": "company",
                "datetime": 1783354301,
                "headline": "What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"
              },
              {
                "id": 140819581,
                "url": "https://finnhub.io/api/news?id=ede26e95f8cd574ded4ee784a40075275bfa1057664adeed1fd210da7b21e2f2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208348437/image_2208348437.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.",
                "category": "company",
                "datetime": 1783327970,
                "headline": "CVS Health: The Surprising Healthcare Outlier"
              },
              {
                "id": 140807752,
                "url": "https://finnhub.io/api/news?id=db7dccf806f73313f5852acc19a832bddeba826f9f5173bb131d4479cbbcd12e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]",
                "category": "company",
                "datetime": 1783174832,
                "headline": "Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”"
              },
              {
                "id": 140799596,
                "url": "https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.",
                "category": "company",
                "datetime": 1783081253,
                "headline": "The Unpopular Move That Telegraphed the Elevance Health Stock Surge"
              },
              {
                "id": 140791579,
                "url": "https://finnhub.io/api/news?id=8dc403fbee8db8aad1d942b0a90f0ef7b4aed8b012426ecb0dbfe2b55e9d2556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.",
                "category": "company",
                "datetime": 1782999120,
                "headline": "PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140772839,
                "url": "https://finnhub.io/api/news?id=6a277ca3b6991ab8e80b88b14bee749319d8ff8f2a6c7597e280f0b5c316b8da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (UNH) is likely to report second-quarter earnings above Wall Street's consensus,",
                "category": "company",
                "datetime": 1782828758,
                "headline": "UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says"
              },
              {
                "id": 140772135,
                "url": "https://finnhub.io/api/news?id=7c0b16820ebd282600b26a580e95b5d32062b8fb552556b1e38962e35c874e2a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 30, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.",
                "category": "company",
                "datetime": 1782820800,
                "headline": "The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants"
              },
              {
                "id": 140771643,
                "url": "https://finnhub.io/api/news?id=933974103b907b1d72be4a7f5132c37cde71a5380376053b69d31f5124d9c4b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DarioHealth Corp. (NASDAQ: DRIO) (the \"Company\", \"DarioHealth\" or \"Dario\"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.",
                "category": "company",
                "datetime": 1782819000,
                "headline": "Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships"
              },
              {
                "id": 140774740,
                "url": "https://finnhub.io/api/news?id=bac1556681a38492c41d8ad99cae5880494ce345262ebc615ded85f7f7858fe6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Two-Injectors-Dosing-Pens-For-Subcutaneo.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility and access.",
                "category": "company",
                "datetime": 1782808093,
                "headline": "Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday"
              },
              {
                "id": 140781618,
                "url": "https://finnhub.io/api/news?id=c2b9cf7db5e8e7b511f80cba972d4339f22d420c6b2bd7054751c0b254645eec",
                "image": "https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.",
                "category": "company",
                "datetime": 1782795601,
                "headline": "Medicare will start covering obesity drugs for the first time. Here's what patients should know"
              },
              {
                "id": 140781757,
                "url": "https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e",
                "image": "https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.",
                "category": "company",
                "datetime": 1782760725,
                "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140762586,
                "url": "https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.",
                "category": "company",
                "datetime": 1782744240,
                "headline": "How CenterWell Is Driving Humana's Growth Beyond Insurance"
              },
              {
                "id": 140761652,
                "url": "https://finnhub.io/api/news?id=ec9490d78d2bbdede75602bb26eb289d1c5b1536c79f6283f5756d1080b4670b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.",
                "category": "company",
                "datetime": 1782737415,
                "headline": "2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 117,
            "discarded_article_count": 99
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 15.6,
        "grade": "較差",
        "items": {
          "bbPoints": 1.8,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.5,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日5日)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 1484716.6666666667,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1390710,
              "avg_vol_20": 1352200,
              "avg_vol_30": 1484716.6666666667,
              "range_pct_10": 0.15702909061054704,
              "range_pct_20": 0.15702909061054704,
              "range_pct_30": 0.2074929585944555,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9366837668241976,
              "dist_to_20d_high": 0.14799011378474158,
              "down_shrink_days": 5,
              "breakout_level_20d": 428.88,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7567923830970092
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.6
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.5,
            "details": {
              "atrPct": 4.582687939574724,
              "turnoverUsdM": 1179.0191166500001,
              "liquidityPoints": 0.8,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 331.9188,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 3
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 9.2,
            "take_profit_price": 406.2414,
            "target_multiplier": 1.9,
            "technical_strength": 1.93,
            "take_profit_percent": 11.2
          },
          "positionPoints": 1.5,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2219902541563157,
          "stopLossPercent": 9.165375879149448,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 16.7456,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.58
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -255.16
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0788
    },
    "kdj": {
      "d": 24.84,
      "j": 14.07,
      "k": 21.25,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 29.54
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 23614535,
      "recentSlope": -322696.5,
      "previousSlope": 10360
    },
    "rsi": 36.28,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 407.3989,
      "position": "SAR喺價上",
      "distancePct": 11.49,
      "previousTrend": "下降"
    },
    "ma50": 365.3706,
    "macd": {
      "macd": 4.628891563920149,
      "trend": "中性偏多",
      "signal": 10.352461759879672,
      "histogram": -5.723570195959523
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 394.1013,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "量價配合",
      "ratio": 2.25,
      "score": 8,
      "avgVolume": 1436103,
      "currentVolume": 3226565
    },
    "derived": {
      "ma20": 395.309,
      "ma50": 365.3706,
      "prevClose": 388.71,
      "avgVolume10": 1556787,
      "avgVolume20": 1436103,
      "changePercent": -5.99,
      "avgVolumeForScore": 1436103
    },
    "ma_cross": {
      "ma20": 395.309,
      "ma50": 365.3706,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 396.8995,
      "prevMa50": 364.1648,
      "spreadPct": 8.19,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 375.3341,
      "upper": 415.2839,
      "position": "下半部"
    },
    "rsi_short": 13.99,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 2.25
    }
  }
}

{
  "close": 365.41,
  "volume": 3226565,
  "changePercent": -5.99
}